Global Direct-to-consumer Genetic Testing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Direct-to-consumer Genetic Testing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Most of the time, genetic testing is done through healthcare providers such as physicians, nurse practitioners, and genetic counselors. Healthcare providers determine which test is needed, order the test from a laboratory, collect and send the DNA sample, interpret the test results, and share the results with the patient. Often, a health insurance company covers part or all of the cost of testing. Direct-to-consumer genetic testing is different: these genetic tests are marketed directly to customers via television, print advertisements, or the Internet, and the tests can be bought online or in stores. Customers send the company a DNA sample and receive their results directly from a secure website or in a written report. Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process.

Market Overview:

The latest research study on the global Direct-to-consumer Genetic Testing market finds that the global Direct-to-consumer Genetic Testing market reached a value of USD 276.6 million in 2022. It’s expected that the market will achieve USD 803.05 million by 2028, exhibiting a CAGR of 19.44% during the forecast period.

Limitations

Fluctuations in raw material prices
Some of the materials will face a fluctuation price trend, which will lead to a higher cost in the Direct-to-consumer Genetic Testing industry, the difficulty in the procurement of raw materials may become a hint factor to this industry.
Potential economic trade protection
Nowadays, some regions are tending to protect their local economy and impede global trade, which may bring resistance to manufacturers' global market strategy.
Strict application for national certification in some regions
Such as FDA and EMA, manufacturers may face difficulties when trying to open the market there, they have to pay attention to those strict requirements and improve their products.

Opportunities

Improve performance
In the future, the manufacturers tend to increase research and development efforts, apply for certification in different regions, improve their productivity and create competitive advantage, such as offering the high-performance product at a cost-effective price point.
Emerging countries
For example, China, India, Southeast Asia, South America, have large populations around the world, with the progress of economy, increase demand for Direct-to-consumer Genetic Testing, reform of medical insurance system, development of local enterprises, the market of Direct-to-consumer Genetic Testing has great market potential in those regions.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

23andMe is one of the major players operating in the Direct-to-consumer Genetic Testing market, holding a share of 76.48% in 2020.

23andMe

23andMe operates as a personal genetics company that provides DNA analysis services. The company offers information and tools for individuals to learn about and explore their DNA. It enables individuals to discover ancestral origins and trace the lineage with a personalized analysis of DNA. The company uses Illumina HumanOmniExpress-24 format chip that comprises a custom panel of probes for detecting genetic variations. Its Personal Genome Service enables individuals to gain deeper insights into their ancestry and inherited traits.

Laboratory Corporation of America

Laboratory Corporation of America, Inc. provides clinical laboratory services. It offers testing services used by the medical profession in the diagnosis, monitoring, and treatment of diseases and other clinical states. The company operates reference laboratory, performing esoteric testing and tests for the presence of drugs of abuse, sales ports, patient service centers, and STAT laboratories.

Segmentation Overview:

Among different product types, Disease Risk and Health segment is anticipated to contribute the largest market share in 2027.

Disease Risk and Health

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. The tests may also look for genetic variations related to other health-related traits, such as weight and metabolism.

Ancestry or Genealogy

The results of these tests provide clues about where a person's ancestors might have come from, their ethnicity, and genetic connections between families.

Kinship

The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing). The results of direct-to-consumer kinship tests, including paternity tests, are usually not admissible in a court of law.

Lifestyle

The results of these tests claim to provide information about lifestyle factors, such as nutrition, fitness, weight loss, skincare, sleep, and even your wine preferences, based on variations in your DNA. Many of the companies that offer this kind of testing also sell services, products, or programs that they customize on the basis of your test results.

Application Overview:

The market's largest segment by application is the segment On-line Sales, with a market share of 77.86% in 2021.

On-line Sales

On-line sales are a form of electronic commerce that allows consumers to directly buy Direct-to-consumer Genetic Testing services from a seller over the Internet using a web browser. Consumers find a product of interest by visiting the website of the retailer directly or by searching among alternative vendors using a shopping search engine, which displays the same product's availability and pricing at different e-retailers.

Doctor’s Office

Doctors' offices are the primary place where ambulatory care is given and are often the first place that a sick person would go for care, except in an emergency, in which case one would go to an emergency department at a hospital

Key Companies in the global Direct-to-consumer Genetic Testing market covered in Chapter 3:

Thermo Fisher
Pathway Genomics
Quest Diagnostics
Myriad Genetics
WeGene
MapMyGenome
Helix
Color Genomics
Gene by Gene
Laboratory Corporation of America
23andMe
African Ancestry

In Chapter 4 and Chapter 14.2, on the basis of types, the Direct-to-consumer Genetic Testing market from 2018 to 2029 is primarily split into:

Disease Risk and Health
Ancestry or Genealogy
Kinship
Lifestyle

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Direct-to-consumer Genetic Testing market from 2018 to 2029 covers:

On-line Sales
Doctor’s Office

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)